Healthpeak Properties, Inc. (NYSE:DOC) Receives $24.15 Average PT from Analysts

Shares of Healthpeak Properties, Inc. (NYSE:DOCGet Free Report) have earned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $24.08.

DOC has been the topic of a number of research analyst reports. Robert W. Baird dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Tuesday. Mizuho cut their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a research note on Wednesday, January 15th. Royal Bank of Canada increased their price target on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th.

Read Our Latest Research Report on Healthpeak Properties

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. CANADA LIFE ASSURANCE Co grew its holdings in shares of Healthpeak Properties by 2.1% during the 4th quarter. CANADA LIFE ASSURANCE Co now owns 1,366,977 shares of the real estate investment trust’s stock worth $27,712,000 after purchasing an additional 27,644 shares in the last quarter. Long Pond Capital LP bought a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $86,885,000. Zacks Investment Management boosted its position in shares of Healthpeak Properties by 6.4% during the 4th quarter. Zacks Investment Management now owns 1,427,638 shares of the real estate investment trust’s stock worth $28,938,000 after acquiring an additional 86,501 shares in the last quarter. NewEdge Advisors LLC increased its stake in Healthpeak Properties by 10.5% in the fourth quarter. NewEdge Advisors LLC now owns 14,409 shares of the real estate investment trust’s stock valued at $292,000 after acquiring an additional 1,371 shares during the last quarter. Finally, Insigneo Advisory Services LLC raised its position in Healthpeak Properties by 9.5% during the fourth quarter. Insigneo Advisory Services LLC now owns 15,455 shares of the real estate investment trust’s stock valued at $313,000 after purchasing an additional 1,339 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Stock Performance

NYSE DOC opened at $19.98 on Friday. The firm has a market capitalization of $13.97 billion, a P/E ratio of 57.07, a price-to-earnings-growth ratio of 2.18 and a beta of 1.15. The company has a current ratio of 1.35, a quick ratio of 1.31 and a debt-to-equity ratio of 0.96. The firm’s fifty day moving average price is $20.43 and its two-hundred day moving average price is $21.48. Healthpeak Properties has a 1 year low of $16.01 and a 1 year high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th will be issued a $0.305 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a yield of 6.11%. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. Healthpeak Properties’s payout ratio is currently 342.87%.

Healthpeak Properties Company Profile

(